Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Plasma cell 1Other solid neoplasm 1Genitourinary 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 126Lenalidomide 74daratumumab 73Bortezomib 61pomalidomide 46carfilzomib 41Cyclophosphamide 41Calcium Dobesilate 38Specimen Handling 34Biopsy 31Magnetic Resonance Spectroscopy 28belantamab mafodotin 24isatuximab 21fludarabine 20dexamethasone acetate 19dexamethasone 21-phosphate 19auricularum 19iberdomide 18Melphalan 18talquetamab 17fludarabine phosphate 12selinexor 11elotuzumab 10X-Rays 10tocilizumab 9Nivolumab 8trametinib 7Sirolimus 7Crizotinib 7Whole-Body Irradiation 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Accelerometry × Plasma cell × 90 days × Clear all
NCT07045727 2026-03-30

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Mayo Clinic

Phase NA Recruiting
20 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡